Stallergenes - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Stallergenes Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Stallergenes. The Group's principal activity is to develop, produce and distribute immunotherapy solutions to treat allergies. The Group offers allergen extracts used to correct the immune imbalance. The Group supplies therapeutic products for diagnostic purpose as well as treatments. Under diagnostic purpose, the Group offers prick tests and vitro tests which help medical professionals to confirm the diagnosis. Under treatments, the Group offers subcutaneous injections, and sublingual drops. The Group operates mainly in France, Spain, Portugal, Italy, Greece and Switzerland.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report